| Q36734437 | Analysis of the effects of oestrogen receptor alpha (ERalpha)- and ERbeta-selective ligands given in combination to ovariectomized rats |
| Q35203007 | Arzoxifene as therapy for endometrial cancer |
| Q35767456 | Cardiovascular actions of selective estrogen receptor modulators and phytoestrogens |
| Q34289780 | Discovery of estrogen receptor modulators: a review of virtual screening and SAR efforts. |
| Q40953602 | Effect of toremifene and ospemifene, compared to acolbifene, on estrogen-sensitive parameters in rat and human uterine tissues |
| Q44127871 | Effects of oral raloxifene on serum estradiol levels and other markers of estrogenicity |
| Q34264079 | Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: a double-blind, randomized trial |
| Q50462181 | Estrogen receptor α is required for oviductal transport of embryos |
| Q34405645 | Peroxisome proliferator-activated receptor (PPAR) modulators: diabetes and beyond |
| Q45008059 | The effects of ovulation induction during infertility treatment on gingival inflammation |
| Q34565110 | Toxicity of antiestrogens |
| Q37634220 | Understanding breast cancer - The long and winding road |
| Q73991166 | Vascular effects of estrogens: arterial protection versus venous thrombotic risk |